| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 02/01/2001 | WO2001007568A2 Muscle cells and their use in cardiac repair |
| 02/01/2001 | WO2001007475A1 Novel peptides |
| 02/01/2001 | WO2001007098A2 A device and method for performing a biological modification of a fluid |
| 02/01/2001 | WO2001007080A2 Method for enhancing production performance in an animal |
| 02/01/2001 | WO2001007073A1 Novel use of hypo-osmotic saline solutions and medicine based on said solutions |
| 02/01/2001 | WO2001007069A1 In vivo induction for enhanced function of isolated hepatocytes |
| 02/01/2001 | WO2001007065A2 PRODUCTION OF rhPBGD AND NEW THERAPEUTIC METHODS FOR TREATING PATIENTS WITH ACUTE INTERMITTENT PORPHYRIA (AIP) AND OTHER PORPHYRIC DISEASES |
| 02/01/2001 | WO2001007060A1 Compositions containing muscle-derived active agents |
| 02/01/2001 | WO2001007059A1 Matrix-targeted fusion polypeptides for tissue regeneration and wound healing |
| 02/01/2001 | WO2001006988A2 Super-active porcine growth hormone releasing hormone analog |
| 02/01/2001 | WO2001006949A2 In vitro repair of bone and/or cartilage defects |
| 02/01/2001 | WO2000066722B1 Collection of prokaryotic dna for two hybrid systems helicobacter pylori protein-protein interactions and application thereof |
| 02/01/2001 | WO2000066720A3 The use of adeno-associated virus (aav) deliver cytoprotective genes |
| 02/01/2001 | WO2000061736A3 Recombinant and mutant marek's disease virus |
| 02/01/2001 | WO2000061724A3 Anti-bacterial vaccine compositions |
| 02/01/2001 | WO2000059518A3 Composition and method for inducing apoptosis in prostate cancer cells |
| 02/01/2001 | WO2000056359A3 Vaccine against streptococcus pneumoniae |
| 02/01/2001 | WO2000050048A3 Bone marrow transplantation for hepatic regeneration and repair |
| 02/01/2001 | WO2000045842A3 Methods for human allografting |
| 02/01/2001 | WO2000009668A9 Engraftable human neural stem cells |
| 02/01/2001 | CA2696819A1 Ghrelin related peptides |
| 02/01/2001 | CA2396591A1 Abc transport polynucleotides, polypeptides, and antibodies |
| 02/01/2001 | CA2380317A1 Human synthetases |
| 02/01/2001 | CA2379937A1 A device and method for performing a biological modification of a fluid |
| 02/01/2001 | CA2379824A1 Novel use of hypo-osmotic saline solutions and medicine based on said solutions |
| 02/01/2001 | CA2378726A1 Compositions containing muscle-derived active agents |
| 02/01/2001 | CA2378643A1 Muscle cells and their use in cardiac repair |
| 01/31/2001 | EP1072271A2 Selective immune down regulation (SIDR) mediated transplantation processes |
| 01/31/2001 | EP1072258A1 Capsule for the release of bacteria, containing lyophilised bacteria and a method for the production thereof |
| 01/31/2001 | EP1071957A1 Isolated nucleic acid molecule encoding cancer associated antigens, the antigens per se, and uses thereof |
| 01/31/2001 | EP1071804A1 Use of triplex structure dna sequences for transferring nucleotide sequences |
| 01/31/2001 | EP1071763A1 Vaccine formulations comprising antiidiotypic antibodies which immunologically mimic group b streptococcal carbohydrates |
| 01/31/2001 | EP1071752A1 CD19xCD3 SPECIFIC POLYPEPTIDES AND USES THEREOF |
| 01/31/2001 | EP1071750A1 Pns cell lines and methods of use therefor |
| 01/31/2001 | EP1071749A1 Novel lrsg protein and nucleic acid molecules and uses therefor |
| 01/31/2001 | EP1071712A1 Sp22, a fertility-associated protein from sperm and a method for evaluating and affecting male fertility using it |
| 01/31/2001 | EP1071459A1 Methods to provoke anti-cancer immune responses |
| 01/31/2001 | EP1071450A2 Combination of antigen pulsed apcs and interleukin 12 for tumour and viral therapy |
| 01/31/2001 | EP1071447A1 Treatment for diabetes |
| 01/31/2001 | EP1071445A2 Therapeutic angiogenic factors and methods for their use |
| 01/31/2001 | EP1071438A2 Stabilised virus preparation |
| 01/31/2001 | EP1071437A1 Streptococcus preparation |
| 01/31/2001 | EP1071436A1 Immune effector cell hybrids |
| 01/31/2001 | EP1071334A1 A method for efficient and highly selective control of microorganisms |
| 01/31/2001 | EP1071333A1 Induction of immunity against tumor self-antigens |
| 01/31/2001 | EP1071325A1 Compositions and methods for antigen-specific vaccination |
| 01/31/2001 | EP0619732B1 Biodegradable polymers for cell transplantation |
| 01/31/2001 | CN1281894A Method for transferring human endostatin gene lactic bacteria, its product and application |
| 01/31/2001 | CN1281865A Microbial polysaccharide, its preparation method and medicine composite containing it |
| 01/31/2001 | CN1281713A Weitong capsule for curing stomach-ache |
| 01/31/2001 | CN1281711A Shaoshang Shengpi powder for curing burn and its preparation method |
| 01/31/2001 | CN1281709A Chinese patent medicine for curing thrombotic disease |
| 01/31/2001 | CN1281708A Medicine for curing stomatocace and its preparation method |
| 01/31/2001 | CN1281706A Chinese medicine composition for curing various cancers |
| 01/31/2001 | CN1281704A Development of yaokang capsule and its clinical application |
| 01/31/2001 | CN1281703A Kechuan Xieling ointment |
| 01/31/2001 | CN1061257C Chinese patent drug for curing rheumatoid disease and preparing method thereof |
| 01/31/2001 | CN1061255C Anti-radioactivity fibration drug |
| 01/31/2001 | CN1061253C Medicine for curing bone disease |
| 01/31/2001 | CN1061252C Chinese medicine oxygen nebulization preparation for curing cardio-cerebral disease and preparing method |
| 01/31/2001 | CN1061251C Chinese patnet drug for curing hemalopia |
| 01/31/2001 | CN1061250C Fast-acting antalgesic medical ointment series |
| 01/31/2001 | CN1061248C Powder agent formula for curing acne and seborrhea and production method |
| 01/31/2001 | CN1061244C Medicine for treating hepatic disease |
| 01/31/2001 | CN1061242C Drug for curing traumatic injuries and preparing method thereof |
| 01/31/2001 | CN1061235C Pharmaceutical composition for prophlaxis and treatment of premature ejaculation caused by neuroticism |
| 01/31/2001 | CN1061234C External-use composition for curing skin ulcer and its preparing method |
| 01/31/2001 | CN1061233C Health-care oral liquor and its producing process |
| 01/30/2001 | US6180762 An antibody specific for human glycyrrhetinic acid-like factor which is not glycyrrhetinic acid or metabolite; said factor inhibits 11beta-hydroxy steroid dehydrogenase and 5beta-steroid reductase; diagnosing hypertension |
| 01/30/2001 | US6180613 AAV-mediated delivery of DNA to cells of the nervous system |
| 01/30/2001 | US6180383 Insect proteolytic enzyme; for the prevention of insect infestation |
| 01/30/2001 | US6180370 Preparing preferential antibodies; generating nucleotide sequences coding preferential antibodies, expressing nucleotide sequences in transformed cell and recovering preferential antibodies |
| 01/30/2001 | US6180142 Reduction of surfactant inactivation in pulmonary surfactant therapy |
| 01/30/2001 | US6180110 Attenuated hepatitis a virus vaccine which grows in MRC-5 cells |
| 01/30/2001 | US6180104 Can be used such as nucleotide probes, combining with foreign dna sequences to produce novel t-cell receptors, which can be used in an analogous manner as antibodies, or constructs can be provided which provide for extrachromosomal elements |
| 01/30/2001 | US6180101 Remedy for axillary osmidrosis containing adrenocorticosteroidal preparation |
| 01/30/2001 | US6180100 Lactobacillus compositions and methods for treating urinary tract infections |
| 01/30/2001 | US6180097 For treatment of solid tumors, including their metastases, without radiation, surgery or standard chemotherapeutic by using superantigens, including staphyloccocal enterotoxins b and c, to stimulate tumor draining lymph node cells |
| 01/30/2001 | US6179826 Implantable therapy systems and methods |
| 01/30/2001 | CA2064558C Method for inhibiting growth of stem cells |
| 01/25/2001 | WO2001006258A1 Method and kit for immuno-detecting bacteria in blood and tissues |
| 01/25/2001 | WO2001006015A1 NOVEL GLYCOSYL SULFOTRANSFERASES GST-4α, GST-4β, AND GST-6 |
| 01/25/2001 | WO2001005991A1 Scleroprotein of an adeno-associated virus with modified chromatographic properties, the production thereof and use of the same |
| 01/25/2001 | WO2001005990A1 Structural protein of adeno-associated virus with modified antigenicity, its production and its use |
| 01/25/2001 | WO2001005983A1 Dsp-11 dual-specificity map kinase phosphatase |
| 01/25/2001 | WO2001005970A2 Gtp-binding protein associated factors |
| 01/25/2001 | WO2001005967A1 Splice variants of cd40-receptor |
| 01/25/2001 | WO2001005944A1 Identification of pluripotent pre-mesenchymal, pre-hematopoietic progenitor cell |
| 01/25/2001 | WO2001005942A2 Improved keratinocyte culture and uses thereof |
| 01/25/2001 | WO2001005941A2 Storage of microorganisms, cells and tissue |
| 01/25/2001 | WO2001005940A2 Methods for producing and preparing cells for cell therapy |
| 01/25/2001 | WO2001005938A1 A method for producing mycelia of ganoderma lucidum containing selenium and other trace elements |
| 01/25/2001 | WO2001005826A2 Chimeric polypeptides of serum albumin and uses related thereto |
| 01/25/2001 | WO2001005820A2 Method for down-regulating gdf-8 activity |
| 01/25/2001 | WO2001005480A2 Chemokine binding protein of gammaherpesvirus 68 and methods of use therefor |
| 01/25/2001 | WO2001005413A1 Use of propionic bacteria for producing propionic acid and/or propionates in the colon |
| 01/25/2001 | WO2001005411A1 Compositions addressing inflammation and/or degenerative disorders |
| 01/25/2001 | WO2000068399A3 Vector-mediated delivery of integrating transposon sequences |
| 01/25/2001 | WO2000065030A3 Microencapsulated genetically engineered e. coli dh 5 cells for the removal of undesired electrolytes and/or metabolites |
| 01/25/2001 | WO2000061156A3 Methods of treating schizophrenia |